Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

May 05, 2015 6:01 PM ET

Company Overview of The University of Massachusetts Medical School

Company Overview

55 Lake Avenue North

Worcester, MA 01655

United States



Key Executives for The University of Massachusetts Medical School

Provost, Executive Deputy Chancellor and Dean of the School of Medicine
Director for Diabetes Center of Excellence and Division Chief of Diabetes
Director for the Cancer Center of Excellence
Senior Director of Human Stem Cell Bank & Registry
Compensation as of Fiscal Year 2014.

The University of Massachusetts Medical School Key Developments

Umass Medical School Consulting Division Announces Executive Changes

Commonwealth Medicine, the consulting division of UMass Medical School has named former state health care policy director Kimberly Haddad as the organization's new chief of staff. Haddad will help the organization as it serves as a consultant for both public and private agencies in 20 states, including Massachusetts, and 27 countries and territories to improve health and human service programs. The appointment completes a months-long search to replace Abigail Averbach, who has become the senior program director of data analytics at Commonwealth Medicine.

LYSOGENE Enters into Strategic Collaboration with University of Massachusetts Medical School and Auburn University

LYSOGENE announced that it has entered into a strategic collaboration with the University of Massachusetts Medical School (UMMS) and Auburn University (AU). Through the collaboration, LYSOGENE, UMMS and AU will develop IND-supporting preclinical studies in GM1-gangliosidosis, a rare, inherited disorder characterized by severe neurological impairment, using adeno-associated virus (AAV) gene therapy technology. The collaboration will combine LYSOGENE's translational and clinical expertise in gene therapy for CNS disorders with the unique preclinical expertise and infrastructure of UMMS and AU to design and test innovative AAV-based gene therapy approaches to treat GM1-gangliosidosis.

Voyager Therapeutics and The University of Massachusetts Medical School Announce Strategic Collaboration for Viral Vector Manufacturing

Voyager Therapeutics announced entered into a strategic collaboration with MassBiologics of the University of Massachusetts Medical School (UMMS). Through the collaboration, MassBiologics and Voyager Therapeutics will establish scalable processes for manufacturing recombinant adeno-associated viral (rAAV) vector products using current good manufacturing practices (cGMP). The collaboration will combine Voyager’s rAAV production technology platform with the manufacturing expertise and infrastructure of MassBiologics. Scientists from Voyager and MassBiologics will work together to establish Voyager’s proprietary third generation baculovirus/Sf9 process for the production of rAAV vectors.

Similar Private Companies By Industry

Company Name Region
Diversified Health Services United States
Carlisle Capital, LLC United States
Destar, L.L.C. United States
generationOn United States
Eye On It Capital, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact The University of Massachusetts Medical School, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at